ADC药物的抗体组成及其作用靶点研究进展*

抗体药物偶联物(antibody-drug conjugates,ADC)是一类由单克隆抗体和小分子细胞毒性药物通过连接子偶联而成的新型生物治疗药物。与传统的细胞毒药物相比,ADC具有靶向性强、毒副作用小等优势,在临床上展现较好的治疗潜力。其中,抗体部分通过与肿瘤细胞表面的靶向抗原结合,精准地将小分子细胞毒性药物递送至肿瘤部位,从而实现肿瘤特异性杀伤效果,是影响ADC疗效的核心要素之一。对近年来ADC药物中抗体的组成及其作用靶点的研究进展进行了综述。     

Her2抗体与MMAE偶联物的制备及生物活性研究

目的:制备Her2抗体与海兔毒素MMAE的偶联物,检测该抗体-药物偶联药物(ADC)对于乳腺癌细胞的抑制作用。方法:将Her2抗体通过一个可降解的linker与小分子毒素(MMAE)连接起来,形成抗体药物偶联物(ADC)。通过细胞学试验检测Her2抗体-MMAE偶联物对于肿瘤细胞抑制、细胞凋亡和细胞周期的作用。结果:通过优化偶联条件,ADC偶联率达80%以上。肿瘤细胞生长抑制的实验显示ADC药物的IC50比单克隆抗体的IC50明显降低,作用效果更加明显。细胞凋亡和细胞周期实验结果表明,ADC药物72h诱导细胞凋亡率高达40%,单一抗体药物则仅为20%。结论:该ADC药物具有很好的抑制乳腺癌细胞的作用。     

抗肿瘤抗体-药物偶联物的临床研究进展

个体化靶向治疗已成为肿瘤临床治疗的新趋势.抗肿瘤靶向药物与传统的细胞毒性化疗药物相比具有特异性高、选择性强和非细胞毒性等优点,近年来发展迅速.抗体-药物偶联物(ADCs)属于抗肿瘤靶向药物,由抗体、“弹头”药物(细胞毒性药物)通过链分子连接而成.ADCs将抗体的靶向性与细胞毒性药物的抗肿瘤作用相结合,可以降低细胞毒性抗肿瘤药物的不良反应,提高肿瘤治疗的选择性,还能更好地应对靶向单抗的耐药性问题.目前,FDA已批准2种ADC药物上市,即Mylotarg和Adcetris,有多种ADCs处于Ⅰ～Ⅲ期临床试验阶段,取得了显著的临床效果.本文概述了以美登素,卡奇霉素、Auristantin等三种细胞毒性药物为“弹头”药物的ADCs药物的临床研究状况及临床试验结果,为ADCs的研究和应用提供参考.     

羊肚菌原生质体制备与再生*

羊肚菌原生质体制备的最佳条件为以培养3d的菌丝体为材料,0.6mol/L蔗糖溶液为稳渗剂,1.5%浓度的溶壁酶30℃条件下酶解3个小时,可得原生质体产量最高为3.35×106个/100mg.以0.6mol/L的蔗糖溶液做稳渗剂,CYM再生培养基上得到原生质体再生率为0.171%.这一研究结果为羊肚菌通过原生质体技术进行菌株的遗传改良提供了重要技术参数.     

十七种哺乳动物二级抗体的制备和辣根过氧化物酶标记

目的制备兔抗17种哺乳动物的二级抗体,并进行辣根过氧化物酶标记,为哺乳血清学检测系统的建立提供工具。方法利用饱和硫酸铵沉淀法粗纯抗体后,再利用protein A或protein G亲和层析的方法进一步纯化哺乳动物的IgG,免疫大耳白兔制备抗血清,利用免疫双扩散来检测抗血清的效价,并用Protein A亲和层析的方法来纯化兔抗哺乳动物的二级抗体,采用简易过碘酸钠法对纯化的兔抗哺乳动物的二级抗体进行辣根过氧化物酶标记,通过ELISA方法测定标记抗体的效价,并利用Western blot方法考察标记抗体的特异性。结果纯化了恒河猴、东北虎、布氏田鼠、黑线姬鼠、斑羚、原驼、果子狸、食蟹猴、梅花鹿、长爪沙鼠、马鹿、骆驼、大仓鼠、豚鹿、熊猴、大耳羊和雪貂等17种哺乳动物的血清IgG,分别免疫大耳白兔制备了这17种哺乳动物的兔抗血清,免疫双扩散法测定兔抗这17种哺乳动物的抗血清效价均达到1∶32,并对纯化的兔抗恒河猴IgG、兔抗东北虎IgG、兔抗布氏田鼠IgG、兔抗黑线姬鼠IgG、兔抗斑羚IgG、兔抗原驼IgG、兔抗果子狸IgG、兔抗食蟹猴IgG、兔抗梅花鹿IgG、兔抗长爪沙鼠IgG、兔抗马鹿IgG、兔抗骆驼IgG、兔抗大仓鼠IgG、兔抗豚鹿IgG、兔抗熊猴IgG、兔抗大耳羊IgG和兔抗雪貂IgG等17种哺乳动物的二级抗体进行了辣根过氧化物酶标记,ELISA测定标记抗体的效价达到1∶（2000～60000）左右,Western blots显示标记抗体具有很好的特异性。结论成功制备了HRP标记的兔抗17种哺乳动物的二级抗体,为哺乳动物血清学检测体系的建立提供了工具。     

十六种鸟类二级抗体的制备和辣根过氧化物酶标记

目的制备兔抗16种鸟类的二级抗体,并进行辣根过氧化物酶标记,为鸟类血清学检测系统的建立提供工具。方法采用水稀释法粗纯抗体后,再利用改良的饱和硫酸铵分级沉淀法,或亲和层析结合饱和硫酸铵沉淀法,或饱和硫酸铵沉淀法结合SDS-PAGE凝胶切胶纯化的方法进一步纯化鸟类的IgY,利用纯化的IgY免疫大耳白兔制备抗血清,用免疫双扩散来检测抗血清的效价,并用Protein A亲和层析的方法来纯化兔抗鸟类的二级抗体,采用简易过碘酸钠法对纯化的兔抗鸟类的二级抗体进行辣根过氧化物酶标记,通过ELISA方法测定标记抗体的效价,并利用Western blots考察标记抗体的特异性。结果纯化了灰雁、鸬鹚、鸵鸟、小鹈、鸽子、鹅、孔雀、鹌鹑、贵妃鸡、草鹭、夜鹭、赤嘴潜鸭、燕鸥、长脚鹬、虎皮鹦鹉、翘鼻麻鸭等16种鸟类的IgY,免疫双扩散法测定兔抗这16种鸟类的抗血清效价均达到1∶32,并对纯化的兔抗灰雁IgY、兔抗鸬鹚IgY、兔抗鸵鸟IgY、兔抗小鹈IgY、兔抗鸽子IgY、兔抗鹅IgY、兔抗孔雀IgY、兔抗鹌鹑IgY、兔抗贵妃鸡IgY、兔抗草鹭IgY、兔抗夜鹭IgY、兔抗赤嘴潜鸭IgY、兔抗燕鸥IgY、兔抗长脚鹬IgY、兔抗虎皮鹦鹉IgY、兔抗翘鼻麻鸭IgY等16种兔抗鸟类IgY的二级抗体进行了辣根过氧化物酶标记,ELISA测定标记抗体的效价达到1∶800～80000左右,Western blots显示标记抗体具有很好的特异性。结论成功制备了辣根过氧化物酶标记的兔抗16种鸟类的二级抗体,为鸟类血清学检测体系的建立提供了工具。     

单分子免疫检测技术研究进展*

早诊断、早发现、早治疗是提升肿瘤患者生存率的主要手段。临床常用的免疫学检测方法如酶联免疫吸附法、化学发光法等,其检测灵敏度多限制在10^-14~10^-12 mol/L,无法满足早期诊断的需求。单分子免疫检测法,可将待检测分子限制在极小空间范围内(nL以下),对检测信号进行绝对计数,从而实现痕量(可达10^-18 mol/L)标志物的检测。这一超高灵敏度技术实现的关键在于将检测范围限制在极小体积内。经过数十年发展,不论是物理隔离还是利用纳米孔,抑或通过改进显微镜性能,均可在极小体积内(10^-21 L)对信号进行检测。目前基于微阵列的SimoA检测系统已成为单分子免疫检测的金标准,Quanterix公司基于此开发的HD-1分析仪已进入市场应用。基于微液滴的单分子免疫检测技术主要限于实验室,但具有床旁检测的优势。重点介绍了基于物理隔离形式如微阵列和微液滴的单分子免疫检测进展,为进一步开发超高灵敏度检测方法并促进未来临床应用提供理论基础。     

抗体与小分子药物一体化的完美“联姻”——解析抗体-药物偶联物之定点偶联

基于单抗的靶向疗法已成为各种癌症的重要治疗手段,抗体与小分子药物一体化的联姻——抗体—药物偶联物（antibody-drug conjugates,ADC）新药获得了突破性进展。传统ADC是将药物与抗体的赖氨酸残基或链间二硫键还原而产生的半胱氨酸残基相偶联 而形成,其稳定性差,易发生聚集,且其中药物易脱落而产生非治疗性毒副作用。而应用近年发展起来的定点偶联技术所获ADC,除均 一性好外,还保留了母体单抗的药动学性质,毒副作用也远低于具有相同偶联比的传统ADC,极有可能发展成为新一代重磅药物。综述 4种ADC定点偶联方法。     

轮换淘选法筛选凝血酶特异的噬菌体抗体*

轮换淘选法; 噬菌体抗体库; 凝血酶特异的单链抗体;     

用单克隆抗体检测微量乙醛—蛋白结合物

用乙醛和小鼠血清白蛋白的结合物免疫BALB/C小鼠.采用高效融合程序制备出只与乙醛反应的单克隆抗体.这种单克隆抗体能够检测1×10~(-3)微摩尔的乙醛,在鉴定酒精摄入量及其对人体有害程度的研究中具有一定意义.     

Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids

Natural products have been used for many medicinal purposes for centuries. Antibody drug conjugates (ADCs) have utilized this rich source of small molecule therapeutics to produce several clinically useful treatments. ADCs based on the natural product maytansine have been successful clinically. The authors further the utility of the anti-cancer natural product maytansine by developing efficacious payloads and linker-payloads for conjugating to antibodies. The success of our approach was realized in the EGFRvIII targeting ADC EGFRvIII-16. The ADC was able to regress tumors in 2 tumor models (U251/EGFRvIII and MMT/EGFRvIII). When compared to a positive control ADC, the efficacy observed was similar or improved while the isotype control ADCs had no effect.     

基于夹心免疫分析的抗体微阵列的构建

目的：建立一种基于夹心免疫分析的抗体微阵列构建的优化方法。方法：将MCP-1的捕获抗体点样于修饰后的玻片,标准抗原加样覆盖所点阵列,生物素标记抗体和链酶亲和素-cy3依次加样孵育, 激光共聚焦扫描仪获取图象并进行数据分析。对捕获抗体浓度、封闭液种类、系统可重复性和定量检测能力、两种因子平行性检测对信号分析的影响及点样后玻片稳定性进行分析和评价。结果：随着捕获抗体浓度的升高,信号强度逐渐增加;2℅ BSA/PBS和5℅ 酪蛋白可作为本系统的封闭液;所构建系统具有较好的可重复性（组内变异 1.3%,组间变异8.7%）和定量分析能力（所建立的抗原浓度-相对信号强度标准曲线相关系数达0.9995）;并实现了两因子的平行性分析和点样后玻片的稳定性。结论：确立了基于夹心免疫分析的抗体微阵列构建的优化方法,为进一步构建多因子定量检测抗体微阵列奠定了基础。     

N’-acyl-N-methylphenylenediamine as a novel proximity labeling agent for signal amplification in immunohistochemistry

We synthesized novel phenylenediamine derivatives and evaluated them as labeling agents to label proteins in close proximity to a single electron transfer catalyst. We found that N’-acyl-N-methylphenylenediamine labels tyrosine effectively in a model experiment using tris(bipyridine)ruthenium (Ru(bpy)₃²⁺) as the single electron transfer catalyst. By changing the substituents on the nitrogen atom of the phenylenediamine derivatives, the electrochemical properties of the labeling agent can be drastically changed. On the other hand, horseradish peroxidase (HRP) also catalyzes the reaction with almost the same oxidation potential as Ru(bpy)₃²⁺ (～+1.1?V). HRP proximity labeling is applicable to signal amplification in immunohistochemistry. We evaluated the phenylenediamine derivatives as labeling agents for HRP proximity labeling and signal amplification, and found that N’-acyl-N-methylphenylenediamine is a novel and efficient agent for signal amplification using HRP in immunohistochemistry.     

抗体偶联药物的技术现状和展望

抗体偶联药物（antibody drug conjugate,ADC）通常由抗体通过链接体与毒素小分子偶联而成,同时具备抗体的高靶向性和小分子药物的高活性,使之作为一种新兴的靶向治疗手段,在肿瘤治疗领域展现出了优秀的疗效和潜力,成为药物研发领域的新热点。目前全球已有14款ADC药物获批上市,处于临床研究阶段的ADC候选药物分子超过140个。为了进一步提高ADC药物的安全性和有效性,近年来涌现出了各种新颖的技术。本文对ADC药物分子的关键元素,包括抗体、链接体、毒素小分子以及偶联技术等方面的最新研究进展进行总结,并讨论其优缺点。期望这些讨论能够帮助增加对ADC药物研究和开发更加系统的理解,为研发出更加高效和安全的ADC药物带来一些思考。     

Enzyme Immunoassay of the Myelin Basic Protein

Abstract: An enzyme immunoassay using a double-antibody solid-phase technique for myelin basic protein (MBP) has been developed. Antisera were prepared by immunizing rabbits with the purified MBP from chick brain. The conjugation of MBP with horseradish peroxidase was performed by the periodate oxidation method in triethanolamine-acetate buffer (pH 8.5). The sample, antiserum, and conjugate were incubated at 4°C for 16 h, after which the insoluble second antibody was added and the reaction mixture was incubated at 4°C for 3 h. The peroxidase activity of the insoluble conjugate was assayed fluorometrically with hydrogen peroxide and 3-( p -hydroxyphenyl)propionic acid as substrates. The method had an analytical range from 50 pg to 1 ng (from 2.3 × 10⁻¹⁵ to 4.5 × 10⁻¹⁴ mol). The within-assay coefficient of variation (CV) was between 4 and 11% and the between-assay CV for 200 and 400 pg of MBP was 5.5 and 7.1%, respectively. A weak cross-reactivity was observed between chick MBP and bovine MBP, while no reactivity was shown with calf thymus histone. The MBP content of the brain during development increased markedly from the 3rd embryonic week to the 3rd post-hatch week (from 0.01 to 2.4 mg/g of fresh tissue), and the adult level was 3.2 mg/g of fresh tissue.     

抗传染性犬肝炎病毒单克隆抗体的制备及鉴定

目的制备传染性犬肝炎病毒单克隆抗体。方法将用纯化的犬腺病毒1型（CAV-1）免疫的BALB／c小鼠脾细胞与SP2／0细胞在聚乙二醇作用下融合,通过酶联免疫吸附试验（ELISA）和免疫酶试验（1EA）筛选,以有限稀释法克隆3次,制备单克隆抗体,并对制备完成的单克隆抗体进行生物学鉴定。结果成功得到2株能稳定分泌抗CAV-1的单克隆抗体杂交瘤细胞,命名为1B、2H3,经鉴定其亚型分别为IgG2a和IgG2a,2株均为kappa链。腹水的ELISA效价可达10^7-10^8,IEA效价可达1：2560—1：5120。该单克隆抗体与CPV、CDV、FPV、CCV病毒无交叉反应。结论成功制备了抗CAV-1单克隆抗体,为进一步建立相关诊断方法奠定了基础。     

金属硫蛋白导向血栓单抗化学偶联体的制备及性质研究

金属硫蛋白（ｍｅｔａｌｏｔｈｉｏｎｅｉｎ,简称ＭＴ）是一类低分子量、富含半胱氨酸的蛋白质,由于１个ＭＴ分子可结合７个金属离子,因此ＭＴ分子具有很强的金属结合特性［１,２］．本文一方面利用ＭＴ分子的高金属结合性能,另一方面利用苏州医学院血液研究所研制成...     

Preparation of horseradish peroxidase-labeled probes

The direct labeling of nucleic acid probes, with horseradish peroxidase (HRP) may be used in many membrane hybridization applications, including Southern blots, Northern blots, colony and plaque screening, PCR products detection/identification. This article describes the preparation method, which involves the labeling of a single-stranded nucleic acid probe with a positively charged HRP-parabenzoquinonepolyethyleneimine complex (labeling reagent). The associated hybridization and posthybridization protocols are relatively simple, which makes probes labeled directly with HRP particularly suitable for large scale screening, where tens or hundreds of blots are processed weekly.     

Preparation of photo-crosslinkable cinnamate modified hyaluronic acid for immobilization of horseradish peroxidase

In this work, a photo-responsive hydrogel membrane based on cinnamate-modified hyaluronic acid (HA-CM) was developed and safely cross-linked under UV light curing. The obtained material was effectively utilized for immobilization of horseradish peroxidase (HRP) enzyme via encapsulation and entrapment strategy with efficiency above 95%. The prepared HA-CM biopolymer was investigated before the UV curing using instrumental and spectral techniques including Fourier transform infrared (FTIR) and nuclear magnetic resonance (NMR). During the UV irradiation, the progress of the cross-linking reaction was monitored by the UV–vis light spectroscopy. In addition, when the photo-induced cross-linking had accomplished, the morphological appearance of the hydrogel membrane was recorded using a scanning electron microscope (SEM). The HRP immobilized in HA-CM membranes displayed remarkable stability against the environmental pH changes especially under alkaline media and shift the optimum pH to 8 compared to the free HRP, which exhibited the highest activity at pH 7. Also, the entrapped enzyme was able to preserve above 85% of its catalytic activity at higher temperature values where the free enzyme had deactivated by approximately 50%. Moreover, HA-CM-HRP maintained 87% of its activity after 10 sequential reuse cycles, which indicate the economic value of the employed immobilization strategy.